Advertisement
Canada markets open in 2 hours 39 minutes

  • S&P/TSX

    21,871.96
    +64.59 (+0.30%)
     

  • S&P 500

    5,010.60
    +43.37 (+0.87%)
     

  • DOW

    38,239.98
    +253.58 (+0.67%)
     

  • CAD/USD

    0.7296
    -0.0005 (-0.07%)
     

  • CRUDE OIL

    81.72
    -0.18 (-0.22%)
     

  • Bitcoin CAD

    90,834.81
    +296.58 (+0.33%)
     

  • CMC Crypto 200

    1,423.51
    +8.75 (+0.62%)
     

  • GOLD FUTURES

    2,317.00
    -29.40 (-1.25%)
     

  • RUSSELL 2000

    1,967.47
    +19.82 (+1.02%)
     

  • 10-Yr Bond

    4.6230
    +0.0080 (+0.17%)
     

  • NASDAQ futures

    17,411.75
    +61.75 (+0.36%)
     

  • VOLATILITY

    16.63
    -0.31 (-1.83%)
     

  • FTSE

    8,068.32
    +44.45 (+0.55%)
     

  • NIKKEI 225

    37,552.16
    +113.55 (+0.30%)
     

  • CAD/EUR

    0.6844
    -0.0006 (-0.09%)
     

Today's Research Reports on Centric Health, CRH Medical, TSO3 and Knight Therapeutics

ACCESSWIRE

NEW YORK, NY / ACCESSWIRE / July 19, 2018 / Research Driven Investing strives to provide investors with free daily equity research reports analyzing major market events. Take a few minutes to register with us free at http://rdinvesting.com and get exclusive access to our numerous research reports and market updates.

RDI Initiates Coverage on:

Centric Health Corporation
https://rdinvesting.com/news/?ticker=CHH.TO

CRH Medical Corporation
https://rdinvesting.com/news/?ticker=CRH.TO

TSO3 Inc.
https://rdinvesting.com/news/?ticker=TOS.TO

Knight Therapeutics Inc.
https://rdinvesting.com/news/?ticker=GUD.TO

ADVERTISEMENT

Centric Health's stock had no change Wednesday, to close the day at $0.275. The stock recorded a trading volume of 44,000 shares, which was below its three months average volume of 188,976 shares. In the last year, Centric Health's shares have traded in a range of 0.25 - 0.82. The stock is currently trading 66.46% below its 52 week high. The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $0.29 is below its 200-day moving average of $0.41. Shares of Centric Health are trading at a Price to Earnings ratio of 13.75. Shares of Centric Health have fallen approximately 46.15 percent year-to-date.

Access RDI's Centric Health Corporation Research Report at:
https://rdinvesting.com/news/?ticker=CHH.TO

On Wednesday, shares of CRH Medical recorded a trading volume of 69,498 shares, which was below the three months average volume of 162,500 shares. The stock ended the day 0.25% higher at 4.04. The share price has gained 117.20% from its 52 week low with a 52 week trading range of 1.86 - 4.76. The company's shares are currently trading above their 200-day moving average. The stock's 50-day moving average of $4.35 is greater than its 200-day moving average of $3.85. Shares of CRH Medical are trading at a Price to Earnings ratio of 46.98. Shares of CRH Medical have gained approximately 22.05 percent year-to-date.

Access RDI's CRH Medical Corporation Research Report at:
https://rdinvesting.com/news/?ticker=CRH.TO

TSO3's stock moved 2.22% lower Wednesday, to close the day at $0.88. The stock recorded a trading volume of 30,100 shares, which was below its three months average volume of 179,126 shares. In the last year, TSO3's shares have traded in a range of 0.56 - 3.27. The share price has gained 57.14% from its 52 week low. The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $0.94 is below its 200-day moving average of $1.26. Shares of TSO3 have fallen approximately 66.02 percent year-to-date.

Access RDI's TSO3 Inc. Research Report at:
https://rdinvesting.com/news/?ticker=TOS.TO

On Wednesday, shares of Knight Therapeutics recorded a trading volume of 96,463 shares, which was below the three months average volume of 130,466 shares. The stock ended the day 1.39% higher at 8.77. The share price has gained 18.83% from its 52 week low with a 52 week trading range of 7.38 - 10.24. The company's shares are currently trading above their 200-day moving average. The stock's 50-day moving average of $8.15 is greater than its 200-day moving average of $7.93. Shares of the company are trading at a Price to Earnings ratio of 69.60. Shares of Knight Therapeutics have gained approximately 5.54 percent year-to-date.

Access RDI's Knight Therapeutics Inc. Research Report at:
https://rdinvesting.com/news/?ticker=GUD.TO

Our Actionable Research on Centric Health Corporation (TSX: CHH.TO) and CRH Medical Corporation (TSX: CRH.TO) and TSO3 Inc. (TSX: TOS.TO) and Knight Therapeutics Inc. (TSX: GUD.TO) can be downloaded free of charge at Research Driven Investing.

Research Driven Investing

We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.

RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.

Disclaimer: This article is written by an independent contributor of RDInvesting.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. RDInvesting.com is neither a registered broker-dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:

Address:

Email:

contact@rdinvesting.com

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: RDInvesting.com